Background Neonatal lupus erythematosus (NLE) is a rare disease associated with transplacental transfer of maternal anti-Ro/anti-Sjögren syndrome A antibodies. The most common manifestations are cutaneous erythema and congenital heart block. Mothers of infants with NLE are either asymptomatic or diagnosed with autoimmune disease. The goal of this study is to investigate the clinical manifestation, prognosis, and association with autoimmune disease in NLE babies and their mothers in Taiwan. Methods Medical records of newborns with NLE and their mothers from two hospitals in Taiwan between January 1999 and January 2009 were reviewed. Twenty-five newborns (one set of twins) and 24 mothers of infants with NLE were included in the study. Clinical data, including characteristics of skin manifestations, the onset of symptoms, and infants' antibody titers, were collected. A diagnosis of NLE was made if the baby had heart block or characteristic skin lesions and maternal antibodies to Sjögren syndrome A/Ro, Sjögren syndrome B/La, or U1 ribonucleoproteins. Questionnaires were used to determine the mother's health status at the time of delivery and in subsequent years. Results Of the infants, 84% had typical cutaneous manifestations of NLE, and 16% presented with congenital heart block without skin changes. The cutaneous lesions appeared on average at 21.7 weeks. Thirteen mothers were initially asymptomatic, and the other 11 remained asymptomatic over a mean follow-up period of 3.9 years. Two mothers developed lupus nephritis. Conclusion There was a lower incidence of observed congenital heart block compared to previously reported NLE studies among Caucasian populations. Most mothers were asymptomatic before the birth of their NLE child, and few developed autoimmune diseases. However, continued follow-up of asymptomatic NLE mothers is recommended due to the chances of developing a life-threatening, systemic autoimmune disease.
Introduction
Neonatal lupus erythematosus (NLE) is a rare disease associated with the transplacental transfer of maternal anti-Ro/antiSjögren syndrome A (SSA) antigen and anti-La/anti-Sjögren syndrome B (SSB) antigen/antibodies. 1 The first case of NLE in Taiwan was reported in 1989. 2 The most common manifestations of NLE are cutaneous rashes and congenital heart block (CHB). Mothers of children with NLE may have an autoimmune disease, or may be completely healthy at the time of delivery. The long-term health of mothers of NLE infants is a concern because it is increasingly evident that autoantibodies can predate the clinical disease by years. 3 While NLE has been extensively documented in the medical literature, these studies have often covered only select populations primarily Caucasian cases. 4, 5 Thus, the primary aim of our study was to investigate the clinical manifestation and prognosis of NLE babies. Our second objective was to perform a survey on the long-term health of the mothers of NLE infants, which has never been reported in Taiwan.
Patients and methods
We retrospectively reviewed the medical records from Chang Gung Memorial Hospital Linkou, and Chang Gung Memorial Hospital, Taipei, Taiwan, between January 1999 and January 2009. Twenty-five infants diagnosed with NLE and their mothers were enrolled in this study. The inclusion criteria were (1) diagnosis of heart block or characteristic cutaneous lesions, and (2) identification of maternal antibodies to the SSA/Ro, SSB/La or U1 ribonucleoproteins (RNP). Clinical data were collected, including skin manifestations, the onset of symptoms, and antibody titers of both infants and mothers. Skin biopsies were obtained from five patients who had cutaneous lesions.
We defined NLE-related hematologic abnormalities as lymphopenia, neutropenia, or thrombocytopenia during the first 6 months of life. NLE-related hepatic diseases were diagnosed as noninfectious hepatitis or neonatal cholestatic liver disease without structural abnormalities. Patients with cutaneous lesions who were not seen by a pediatric dermatologist or followed up at a clinic regularly were excluded from this study, as were patients with cardiac disorders who were not diagnosed by a pediatric cardiologist through electrocardiograms.
A telephone questionnaire was used to investigate the health status of the infants with NLE and their mothers, including symptoms characteristic of systemic lupus erythematosus (SLE) and Sjögren's syndrome. All affected infants and their mothers were followed for at least 6 months.
Mothers were diagnosed as having SLE or Sjögren's syndrome by using American College of Rheumatology criteria. 6 Undifferentiated autoimmune syndromes (UAS) were defined as absence of sicca syndrome and not meeting the SLE criteria of the American College of Rheumatology. Although the maternal health information was based on data gathered from the telephone questionnaire, information obtained from the mothers who were diagnosed with SLE or Sjögren's syndrome was verified from the medical records in our hospital.
Results
Twenty-five patients (14 males, 11 females, including 1 set of twins), and 24 mothers of NLE infants were enrolled. Most of the babies were full term. Three infants (Cases 12, 24, and 25) were born prematurely at a gestational age of 32, 34 and 34 weeks, respectively. The clinical manifestations of NLE in all patients are listed in Table 1 .
Clinical characteristics of affected children
No infants presented with a cardiac conduction problem and cutaneous NLE simultaneously. Twenty-one patients (84%) had typical cutaneous manifestations of NLE, and 4 (16%) presented with CHB without skin changes. Two infants were diagnosed with third-degree heart block. Heart block was identified in three of the fetuses before birth, leading to premature delivery. Two infants diagnosed with CHB had patent ductus arteriosus (Cases 12 and 24). Transient hematologic abnormalities with cutaneous NLE were observed in two patients (8%). This included one case with anemia (Case 11) and one case with both thrombocytopenia and anemia (Case 10). Hepatic disorders and other evidence of NLE were seen in 2 patients (8%). One infant with cutaneous NLE had elevated transaminase levels (Case 4), and one infant with heart block showed both elevated transaminase levels and hepatomegaly (Case 12). These symptoms were self-limited and there were no longterm complications.
Onset, duration and characteristics of cutaneous lesions
Among the 21 infants with cutaneous NLE lesions, the mean age of onset was 18 days. The rash was present in two patients at birth, in eight patients by 2 weeks of age, in nine patients between 2 and 4 weeks of age, and in two patients after 4 weeks of age.
Sixteen infants had a subcutaneous lupus erythematosuslike eruption consisting of annular scaly plaques, and five others had erythematous-edematous, urticaria-like lesions ( Figure  1 ). All 21 patients had facial involvement, and 13 (60%) had periorbital lesions. In 17 patients (81%), lesions were also noted on the scalp, in 15 patients (71%) on the trunk, and in 11 patients (52%) on both the extremities and trunk. Ten of the infants (48%) presented with widespread lesions.
Skin biopsy results
Five infants had a skin biopsy taken. Histological findings and immunofluorescence results are listed in Table 2 . One patient (Case 20) had typical findings, including vacuolar changes of both basal cells and adnexal structures. Another infant (Case 3) presented with isolated areas of vacuolar alterations at the dermo-epidermal interface. Mucinosis alone was noted in one patient (Case 22), which was consistent with but not specific to cutaneous lupus. Biopsy specimens from two infants (Cases 2 and 19) showed perivascular and periadnexal lymphocytic infiltrates; both infants had clinical and 2 mothers (8%) had SLE. Five mothers (21%) had Sjögren's syndrome, and three mothers (13%) had UAS ( Figure 2 ). One mother had both SLE and Sjögren's syndrome. Among the 13 mothers who were initially asymptomatic, 11 remained asymptomatic for a mean follow-up period of 3.9 years (range: 8 months to 10.3 years). The mother of one patient (Case 25) developed SLE after 6 months; she presented with seizures, skin rashes, and nephritis. The mother of another infant (Case 2) developed Sjögren's syndrome after 1.5 years. One mother was initially categorized as having UAS but fulfilled sufficient criteria for SLE when a skin rash and nephritis occurred 2 years after the birth of her NLE infant (Case 6). Mothers with SLE at the time of the affected pregnancy did not experience progression of their disease.
Discussion
Our study showed a much lower incidence of CHB among Taiwanese patients (16%) than the reported incidence among Caucasians, estimated to be higher than 50%. 4 ,5 A recent Japanese study 7 showed an even lower incidence of CHB (15%). Interestingly, our study found no concurrent cutaneous lesions and CHB. There is no reliable way to predict which organs will be affected. 1 This may support the annular urticaria-like lesions. The results of direct immunofluorescence studies were negative in all cases.
Prognosis of infants with NLE
The mean duration of NLE cutaneous lesions was 21.7 weeks (range: 18 to 27 weeks). In all patients, erythematous eruption lesions disappeared spontaneously without atrophy or remnant pigmentation in parallel with the disappearance of serum antibodies. Two patients had residual facial telangiectatic macules. All the patients received low-potency topical corticosteroid treatment. No patients received systemic glucocorticoid therapy. A male infant with CHB died from congestive heart failure at 24-36 hours of age. Of the three remaining children with congenital heart block, all required pacemakers but were otherwise healthy.
Patients were followed for a mean of 3.9 years (range: 8 months to 10.3 years). No child in our cohort developed symptoms of autoimmune disease.
Clinical characteristics of the mothers
The mean age of the mothers of NLE infants was 28.1 years. At the time of delivery, 13 mothers (54%) were asymptomatic, The main source of morbidity and mortality in NLE is from CHB. One of four children (25%) with cardiac NLE died in our series, and of those who survived, all required permanent pacemakers. Complete CHB develops in 2% of fetuses of Ro/SSA-positive mothers. 10 Approximately 15%
of mothers with these antibodies have infants with CHB in subsequent pregnancies. 11 Detection of maternal Ro/La autoantibodies during pregnancy warrants careful and close monitoring of the fetus with serial echocardiograms between 18 weeks and 24 weeks. Previous reports 1, 5 have noted that half or more mothers of affected infants are asymptomatic, despite having autoantibodies. In our study, most mothers were initially asymptomatic, and the most common rheumatic disease was Sjögren's syndrome. Several long-term studies have indicated that, with time, mothers who are initially asymptomatic may develop signs and symptom of autoimmunity. 3, 12, 13 In the recent large study done by Rivera et al, 3 26 of the 51 neonatal lupus mothers who were initially asymptomatic progressed to autoimmune disease at a median duration of 3.15 years. Most developed only mild symptoms (i.e. photosensitivity and arthralgia). Our study showed that only 2 of the 13 asymptomatic mothers (15.38%) developed autoimmune disease, and one mother with UAS progressed to SLE. Smaller case numbers may explain this difference with the Rivera et al 3 data. While a lower percentage of the asymptomatic mothers progressed to autoimmune disease in our study, cases developed as a life-threatening disease such as lupus nephritis and lupus-related neurological disorders. Thus, long-term follow-up is still suggested. The few studies that have described results of long-term follow-up of children with NLE show that those exposed to anti-Ro autoantibodies and who develop the disease may be genetically or environmentally predisposed to develop clinically overt autoimmunity. 2, 4 Neiman et al 14 reported that 4 of the 57 children with NLE developed autoimmune disease within a mean follow-up period of 77 months. Martin et al 15 also reported that 6 of the 49 children with NLE hypothesis that the mechanism that causes CHB differs from the mechanism that causes cutaneous NLE. 8 The differences in the clinical presentations of our patients compared with those in the previous two studies of NLE are shown (Table 3 4,7 ).
Most of our patients with cutaneous NLE had lesions similar to subacute cutaneous lupus erythematosus, and presented with erythematous scaling and annular plaques on sun-exposed areas. Notably, the second most frequent skin lesions presented as annular erythematous-edematous lesions, which were easily misdiagnosed as urticaria, especially when no periorbital area was affected. Five cases of cutaneous NLE occurred following phototherapy for neonatal jaundice. It is unclear whether phototherapy had anything to do with the development of skin lesions because other infants who did not receive phototherapy still developed the eruptions.
This study provided new data on histopathological findings of cutaneous NLE. The most frequently described histological features are interface changes with vacuolar alteration on the basement membrane at the dermo-epidermal junction and superficial lymphohistiocytic chronic inflammatory cell infiltrates, which corresponded to typical erythematousdesquamative lesions in most patients. Recently, Peñate et al 9 reported the results of seven biopsies from five NLE patients showing epidermal interface changes or superficial and deep perivascular and periadnexal lymphocytic infiltrates without epidermal alteration. In our study, only two patients had epidermal basal cell vacuolar degeneration. Of note, two patients had dermal perivascular and periadnexal lymphocytic infiltrates associated with urticaria-like lesions. Negative immunofluorescence results were found in all biopsied cases. This may be attributed to the short half-life of dermal IgG deposits or to their rapid clearance. When we reviewed the literature, 9 positive immunofluorescence results were reported in fewer than 50% of NLE cases. 
Conclusion
In our study, there was a lower incidence of observed CHB compared to prior NLE cases reported among Caucasian populations, and none of our patients had concurrent CHB and skin lesions. Most mothers were asymptomatic before the birth of their NLE child, and few developed autoimmune diseases. However, continued follow-up of asymptomatic NLE mothers is important, due to the chance that the mother may develop a life-threatening, systemic autoimmune disease.
